CAMPISI, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 1.138
AS - Asia 940
EU - Europa 662
AF - Africa 148
SA - Sud America 92
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.982
Nazione #
US - Stati Uniti d'America 1.098
SG - Singapore 373
CN - Cina 322
RU - Federazione Russa 297
IT - Italia 207
KR - Corea 83
CI - Costa d'Avorio 81
BR - Brasile 80
VN - Vietnam 49
FR - Francia 32
BD - Bangladesh 31
IE - Irlanda 31
GB - Regno Unito 28
IN - India 25
SN - Senegal 23
CA - Canada 22
FI - Finlandia 17
HK - Hong Kong 12
NG - Nigeria 12
NL - Olanda 12
BJ - Benin 10
MX - Messico 10
ZA - Sudafrica 9
JP - Giappone 8
DE - Germania 7
ES - Italia 7
PL - Polonia 7
IQ - Iraq 5
SE - Svezia 5
AR - Argentina 4
KE - Kenya 4
LT - Lituania 4
PH - Filippine 4
TR - Turchia 4
EC - Ecuador 3
JO - Giordania 3
MA - Marocco 3
UA - Ucraina 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
CH - Svizzera 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
MY - Malesia 2
OM - Oman 2
UZ - Uzbekistan 2
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
LB - Libano 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.982
Città #
Singapore 253
Santa Clara 204
Dallas 189
Hefei 166
Moscow 123
San Jose 109
Ashburn 100
Seoul 82
Abidjan 81
Chicago 53
Los Angeles 52
Beijing 41
Civitanova Marche 34
Boardman 33
Dublin 31
Lauterbourg 26
Dakar 23
Milan 21
New York 20
Catania 19
Council Bluffs 18
Ho Chi Minh City 17
Zafferana Etnea 15
Buffalo 13
Orem 13
Lappeenranta 12
Chandler 11
Cotonou 10
Hanoi 10
Lagos 10
Montreal 10
São Paulo 10
Palermo 9
Rome 9
Hong Kong 8
Brooklyn 7
Johannesburg 7
Kochi 7
Phoenix 7
Warsaw 7
Amsterdam 6
Chennai 6
Giarre 6
Houston 6
Tokyo 6
Charlotte 5
Manchester 5
Pune 5
Stockholm 5
Atlanta 4
Bari 4
Helsinki 4
London 4
Messina 4
Munich 4
Paris 4
Poplar 4
San Francisco 4
Toronto 4
Treviso 4
Turin 4
Amman 3
Ankara 3
Boydton 3
Madrid 3
Mascalucia 3
Pittsburgh 3
Praia Grande 3
Querétaro 3
Rio de Janeiro 3
Seattle 3
The Dalles 3
Washington 3
Abbiategrasso 2
Abuja 2
Astoria 2
Baghdad 2
Bitonto 2
Botucatu 2
Cagliari 2
Cesa 2
Corato 2
Da Nang 2
Denver 2
Dong Ket 2
Fortaleza 2
Giulianova 2
Guayaquil 2
Juneau 2
Kansas City 2
Kyiv 2
Laives 2
Legnano 2
Memphis 2
Muscat 2
Naples 2
Quảng Ngãi 2
Reggio Emilia 2
Ribeirão das Neves 2
Richmond 2
Totale 2.058
Nome #
Female Sex Affects Respiratory Function and Exercise Ability in Patients Recovered from COVID-19 Pneumonia 160
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 149
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 136
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 134
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 132
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 128
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 127
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 124
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 119
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 116
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 115
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 112
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients 109
Insuline resistance and insuline sensibility in patients with obstructive sleep apnea 104
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study 103
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study 102
Diagnostic delay in bronchiectasis: an Italian perspective 99
Impact of asthma on bronchiectasis severity and risk of exacerbations 98
Personalized Medicine in Asthma: Current Approach and Future Perspectives 97
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 92
Better outcomes for everybody evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19 91
Sleep quality and mental health during the COVID-19 pandemic in patients with severe obstructive sleep apnea 90
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 89
Tezepelumab for asthma 82
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 81
Comparability of asthma control test scores between self and physician-administered test 81
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 73
Switching Biological Therapies in Severe Asthma 58
High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial 17
Totale 3.018
Categoria #
all - tutte 9.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 0 1 0 0 1 0 1 0 0 0 0 2
2022/2023148 1 0 1 4 4 2 53 40 22 10 2 9
2023/2024232 7 32 23 16 9 53 4 27 2 5 43 11
2024/2025756 11 101 56 40 147 109 30 17 20 52 86 87
2025/20261.833 127 226 248 111 238 377 164 30 80 104 80 48
2026/202736 36 0 0 0 0 0 0 0 0 0 0 0
Totale 3.018